TABLE 2.
Infant characteristics during follow‐up
| Birth | 11 weeks | 25 weeks | |
|---|---|---|---|
| N participants | 50 | 48 | 48 |
| With a vitamin C measure | 40 | 37 | 33 |
| With a stool culture | 36 | 25 | 33 |
| With a vitamin C measure and a stool culture | 29 | 22 | 29 |
| Stuntinga | 11/50 (22.0%) | 9/39 (23.1%) | 9/35 (25.7%) |
| Low birth weight (<2500 g) | 5/50 (10.0%) | ||
| Female | 26/50 (52.0%) | 24/48 (50.0%) | 24/48 (50.0%) |
| Weight (g) | 3175 (2750; 3300) | 5835 (5330; 6500) | 7350 (7000; 7900) |
| Length (cm) | 48 (47; 50) | 58 (56; 49.15) | 66 (63.5; 67.5) |
| Positive stool culture | 8/36 (22.2%) | 20/25 (80.0%) | 27/33 (81.8%) |
| Positive stool culture among infants with a vitamin C measure | 8/29 (27.6%) | 17/22 (77.3%) | 24/29 (82.8%) |
| Albumin (g/L) | 40.5 (38; 43) | 42 (40; 44) | 42 (40; 44) |
| Inflammation (CRP > 5 mg/L) | 4 (10.0%) | 7/36 (19.4%) | 6/33 (18.2%) |
| Vitamin C seric levels (μmol/L) | 35.2 (16.5; 63.9) | 41.5 (18.7; 71.6) | 18.2 (2.3; 46.6) |
| Vitamin C hypovitaminosis (<28 μmol/L) | 17/40 (42.5%) | 13/37 (35.1%) | 18/33 (54.6%) |
| Vitamin C deficiency (<11 μmol/L) | 6/40 (15.0%) | 9/37 (24.3%) | 11/33 (33.3%) |
| Vitamin A seric levels (μmol/L) | 1.3 (1.1; 1.4) | 0.8 (0.9; 1.2) | 0.9 (0.7; 1.0) |
| Vitamin A deficiency (<1 μmol/L) | 6/25 (24.0%) | 20/31 (64.5%) | 22/30 (73.3%) |
| Vitamin E seric levels (μmol/L) | 7.2 (4.1; 8.5) | 16.4 (9.9; 22.4) | 11.2 (6.8; 18.1) |
| Vitamin E deficiency (<11.6 μmol/L) | 22/25 (88.0%) | 11/32 (34.4%) | 17/31 (54.8%) |
Note: For continuous variables, median and inter‐quartile range are provided. For binary and variables with categories, n and percentages are provided.
a
Stunting is defined according to −2 standard deviations of length‐per‐age databases of the WHO.